News

Stay up to date with everything Adastra and the cannabis industry

Adastra Labs Holdings Ltd. Announces Submission of Sales Licence Amendment

LANGLEY, BC / ACCESSWIRE / August 5, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a  Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the submission of its federal sales licence amendment to Health Canada. “The submission of sales licence amendment is significant as it represents the successful operationalization of

Read More »

Adastra Announces Phyto Extractions Vape Cartridge Order

LANGLEY, BC / ACCESSWIRE / July 15, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of a purchase order for 30,000 vaporizing cartridges from CannMart  Inc. (“CannMart”) a majority owned subsidiary of Namaste Technologies Inc. (“Namaste”) (TSX-V: N) (FRANKFURT: M5BQ)

Read More »

Adastra Closes $3.49 Million Oversubscribed Private Placement

LANGLEY, BC/ ACCESSWIRE / July 14, 2020 / Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) is pleased to announce the closing of its previously announced non-brokered private placement offering (see press releases dated June 18, 2020 and June 25, 2020) issuing 11,648,001 units (the “Units”) for aggregate gross proceeds of $3,494,400.

Read More »

Adastra Increases Private Placement Financing

LANGLEY, BC/  June 25, 2020 / Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a  Health Canada Licensed cannabis processing and analytical testing services company announces that it plans to increase its previously announced private placement offering (see press release dated June 18, 2020), of units (the “Units“) at a price of $0.30

Read More »

Adastra Announces Private Placement Financing

June 18, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a  Health Canada Licensed cannabis processing and analytical testing company announced today that it will be conducting a non-brokered private placement of units (the “Units“) at a price of $0.30 per Unit for gross proceeds of up to $1,000,000 (the “Offering“),

Read More »

Adastra Provides Update On Annual and Interim Financial Statements

May 29, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”), a  Health Canada Licensed cannabis processing and analytical testing services Company, announces, further to Adastra’s April 24, 2020 news release in relation to the timing of the filing of its year-end financial statements, the corporation now expects to file such documents on or prior to June

Read More »

Contact Us

Have a question? Want more information? Looking for a partner to deliver the exceptional service you need for your future business? If you're passionate about cannabis, we'd love to hear from you.

F: 844-874-9893
E: info@adastralabs.ca

5451 275th Street,
Langley, BC, Canada, V4W 3X8

Scroll to Top